Guardion Health Sciences

About:

Guardion Health Sciences is dedicated to applying a scientific discipline and pharmaceutical approach
to the development of safe.

Website: http://guardionhealth.com/

Twitter/X: GuardionHealthS

Description:

Guardion is an ocular health sciences company that develops, formulates and distributes conditionspecific medical foods supported by evidence-based protocols, with an initial medical food product that addresses a depleted macular protective pigment, a known risk factor for age-related macular degeneration (“AMD”), and a significant component of functional vision performance. Guardion Health Sciences, Inc. has also developed a proprietary medical device, the MapcatSF®, which accurately measures the macular pigment density, therefore providing the only two-pronged evidence-based protocol for the treatment of a depleted macular protective pigment.

Total Funding Amount:

$9.8M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2009-01-01

Contact Email:

CustomerCare(AT)GuardionHealth.com

Founders:

Michael Favish

Number of Employees:

11-50

Last Funding Date:

2017-11-03

IPO Status:

Public

Industries:

© 2025 bioDAO.ai